Singleron Biotechnology Co., Ltd., a startup company that focuses on high-throughput single-cell multi-omics platform products, announced the completion of a US$30 million series A financing.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?